about

experdata revolutionizes how scientific experts connect and engage with each other in order to answer key research questions in healthcare.

Developer of a drug-disease matching platform designed to facilitate efficient and ethical drug development and positioning. The company's platform leverage the power of AI-based machine learning with a transformative single cell in vitro and in vivo transgenesis to identify new compounds or to repurpose known compounds for the treatment of cardiovascular and cardiometabolic and cancer, enabling medical researchers to reduce the cost, time, and ethical burden of preclinical research. Keywords: Pharmaceuticals and Biotechnology, Cardiometabolic Disease, Cardiovascular Disease, Drug Development Therapy, Drugs Screening Platform, Genome Analysis, Heart Disease Therapy, Heart Disease Treatment, Pharmatech Company, Platform Company, Target Identification. — this profile has been compiled from public sources. The founders haven't yet claimed it.